Anti-ENPP7/ ALK-SMase/ E-NPP 7 monoclonal antibody

Anti-ENPP7/ ALK-SMase/ E-NPP 7 antibody for FACS & in-vivo assay

Target products collectionGo to ENPP7/ENPP7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0413-Ab-1/ GM-Tg-hg-MP0413-Ab-2Anti-Human ENPP7 monoclonal antibodyHuman
GM-Tg-rg-MP0413-Ab-1/ GM-Tg-rg-MP0413-Ab-2Anti-Rat ENPP7 monoclonal antibodyRat
GM-Tg-mg-MP0413-Ab-1/ GM-Tg-mg-MP0413-Ab-2Anti-Mouse ENPP7 monoclonal antibodyMouse
GM-Tg-cynog-MP0413-Ab-1/ GM-Tg-cynog-MP0413-Ab-2Anti-Cynomolgus/ Rhesus macaque ENPP7 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0413-Ab-1/ GM-Tg-felg-MP0413-Ab-2Anti-Feline ENPP7 monoclonal antibodyFeline
GM-Tg-cang-MP0413-Ab-1/ GM-Tg-cang-MP0413-Ab-2Anti-Canine ENPP7 monoclonal antibodyCanine
GM-Tg-bovg-MP0413-Ab-1/ GM-Tg-bovg-MP0413-Ab-2Anti-Bovine ENPP7 monoclonal antibodyBovine
GM-Tg-equg-MP0413-Ab-1/ GM-Tg-equg-MP0413-Ab-2Anti-Equine ENPP7 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0413-Ab-1/ GM-Tg-hg-MP0413-Ab-2; GM-Tg-rg-MP0413-Ab-1/ GM-Tg-rg-MP0413-Ab-2;
GM-Tg-mg-MP0413-Ab-1/ GM-Tg-mg-MP0413-Ab-2; GM-Tg-cynog-MP0413-Ab-1/ GM-Tg-cynog-MP0413-Ab-2;
GM-Tg-felg-MP0413-Ab-1/ GM-Tg-felg-MP0413-Ab-2; GM-Tg-cang-MP0413-Ab-1/ GM-Tg-cang-MP0413-Ab-2;
GM-Tg-bovg-MP0413-Ab-1/ GM-Tg-bovg-MP0413-Ab-2; GM-Tg-equg-MP0413-Ab-1/ GM-Tg-equg-MP0413-Ab-2
Products NameAnti-ENPP7 monoclonal antibody
Formatmab
Target NameENPP7
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ENPP7 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ENPP7/ ALK-SMase/ E-NPP 7 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP001773human ENPP7 Lentivirus plasmid
    ORF Viral VectorvGMLP001773human ENPP7 Lentivirus particle


    Target information

    Target IDGM-MP0413
    Target NameENPP7
    Gene ID339221,238011,303729,717416,608627,101085334,505388,100057000
    Gene Symbol and SynonymsALK-SMase,E-NPP 7,ENPP7,Gm254,NPP-7,NPP7
    Uniprot AccessionQ6UWV6,Q5EZ72
    Uniprot Entry NameENPP7_HUMAN,ENPP7_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000182156
    Target ClassificationN/A

    The target: ENPP7, gene name: ENPP7, also named as ALK-SMase, E-NPP 7, NPP-7, NPP7. The protein encoded by this gene is an intestinal alkaline sphingomyelin phosphodiesterase that converts sphingomyelin to ceramide and phosphocholine. The encoded protein is anchored in the cell membrane, and it may function to protect the intestinal mucosa from inflammation and tumorigenesis. This protein is glycosylated and also exhibits lysophosphatidylcholine hydrolase activity. [provided by RefSeq, Oct 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.